WallStreetZenWallStreetZen

NASDAQ: CAPR
Capricor Therapeutics Inc Stock Ownership - Who owns Capricor Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Capricor Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Anthony BergmannCHIEF FINANCIAL OFFICER2026-05-183,000$1.39
$4.17kBuy
Frank LitvackDirector2026-05-133,937$1.39
$5.47kBuy
Karen KrasneyEVP GENERAL COUNSEL2026-05-0125,000$31.70
$792.55kSell
Anthony BergmannCHIEF FINANCIAL OFFICER2026-05-0125,000$3.18
$79.50kBuy
Karen KrasneyEVP GENERAL COUNSEL2026-05-0125,000$3.18
$79.50kBuy
Anthony BergmannCHIEF FINANCIAL OFFICER2026-05-0125,000$31.70
$792.55kSell
Karimah Es SabarDirector2026-04-027,529$3.18
$23.94kBuy
Karimah Es SabarDirector2026-04-027,529$32.00
$240.93kSell
Karimah Es SabarDirector2026-04-0153,735$4.86
$261.15kBuy
Karimah Es SabarDirector2026-04-0153,735$31.03
$1.67MSell

1 of 2

CAPR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CAPR insiders and whales buy or sell their stock.

CAPR Shareholders

What type of owners hold Capricor Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Nippon Shinyaku Co Ltd12.24%7,090,351$189.45MInsider
Fountainhead Capital Partners Ltd9.59%5,551,000$148.32MInsider
Sinai Medical Center Cedars6.99%4,049,959$108.21MInsider
Suvretta Capital Management LLC6.59%3,818,600$102.03MInstitution
Blackrock Inc5.91%3,421,815$91.43MInstitution
Tang Capital Management LLC5.87%3,399,900$90.85MInstitution
Eduardo Marban5.71%3,307,863$88.39MInsider
John Edward A. St5.36%3,101,574$82.87MInsider
Louis J. Grasmick5.07%2,937,729$78.50MInsider
Peter M. Kash5.04%2,920,446$78.03MInsider

1 of 3

CAPR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CAPR46.48%53.52%Net BuyingNet Buying
FTRE99.13%0.87%Net SellingNet Selling
NVAX71.75%17.12%Net Selling
GLUE41.86%58.14%Net SellingNet Selling
ATAI27.07%32.65%Net BuyingNet Buying
View Top Biotech Stocks

Capricor Therapeutics Stock Ownership FAQ

Who owns Capricor Therapeutics?

Capricor Therapeutics (NASDAQ: CAPR) is owned by 58.41% institutional shareholders, 67.27% Capricor Therapeutics insiders, and 0.00% retail investors. Nippon Shinyaku Co Ltd is the largest individual Capricor Therapeutics shareholder, owning 7.09M shares representing 12.24% of the company. Nippon Shinyaku Co Ltd's Capricor Therapeutics shares are currently valued at $184.70M.

If you're new to stock investing, here's how to buy Capricor Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.